Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000674786 | SCV000800183 | likely pathogenic | Deficiency of galactokinase | 2018-05-23 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000674786 | SCV001584384 | pathogenic | Deficiency of galactokinase | 2023-05-31 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 558505). This variant has not been reported in the literature in individuals affected with GALK1-related conditions. This variant is present in population databases (rs770087254, gnomAD 0.008%). This sequence change creates a premature translational stop signal (p.Ile285Argfs*4) in the GALK1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GALK1 are known to be pathogenic (PMID: 7670469, 10790206). |
Revvity Omics, |
RCV000674786 | SCV002025246 | likely pathogenic | Deficiency of galactokinase | 2021-04-22 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000674786 | SCV004197924 | likely pathogenic | Deficiency of galactokinase | 2023-10-24 | criteria provided, single submitter | clinical testing |